SMX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. SMX is in a strong short-term downtrend (down 17.6% today) and is trading right on/just below key support (13.865). With no proprietary buy signals, no supportive news catalysts, and bearish moving-average structure, the risk of a continued breakdown toward the next support (~10.644) outweighs the oversold-bounce potential.
Price/Trend: Sharp selloff (-17.56% regular session) with price at 13.81, sitting essentially on S1 (13.865). A decisive hold above this level could spark a reflex bounce, but a break/close below increases odds of a move toward S2 (~10.644). Momentum: RSI(6)=26.11 (oversold/washed-out). This can enable short bounces, but oversold alone is not a buy signal in a falling trend. MACD: Histogram +1.613 and expanding, which suggests improving momentum vs. prior days, but it conflicts with the broader bearish trend structure. Moving Averages: Bearish stack (SMA200 > SMA20 > SMA5) confirms the prevailing downtrend and weak intermediate-term structure. Levels: Pivot 19.08 (far overhead); resistance at 24.294/27.515 is well above. Near-term support: 13.865 then 10.644. Pattern-based forward look (provided): ~50% chance of -0.78% next day; +3.03% next week; +6.72% next month—modest upside expectations that do not offset current breakdown risk for an impatient entry.
Intellectia Proprietary Trading Signals
~
near a defined support level (S1 ~13.
could produce a short-lived technical bounce if support holds. MACD histogram is positive and expanding, hinting at improving momentum versus the immediate past.
signals an established downtrend. Price is at/just below key support (13.865); if it fails, downside to ~10.644 becomes the next clear technical target. No recent news catalysts to reverse sentiment. No proprietary Intellectia buy signals today/recently.
Financial snapshot unavailable (data error: list index out of range), so latest-quarter growth trends and quarter/season cannot be assessed from the provided data.
No analyst rating/price target data was provided, so there are no observable recent rating upgrades/downgrades or price target changes to summarize. Wall Street pros/cons view cannot be reliably assessed from the supplied dataset. Hedge funds and insiders are reported as neutral with no significant recent trading trends, and there is no recent Congress trading data available.
